Teva Europe on Twitter: "Today at #IHC2021 we're hosting an online symposium on the CGRP Monoclonal Antibodies treatment landscape for #migraine prevention. Tune in here at 17:45-19:15 CET https://t.co/JF0BFg56el https://t.co/X6TaHSZCTu" / Twitter
Heptares to Receive $5M Milestone Payment from Teva for Migraine Molecule - Drug Discovery and Development
Frontiers | Protective Role of α-Calcitonin Gene-Related Peptide in Cardiovascular Diseases | Physiology
CGRP antagonists – the headache drugs | LGC Standards
Migraine therapies targeting the CGRP pathway: intellectual property landscape | Nature Reviews Drug Discovery
CGRP: Paving the Path to Migraine and Its Treatment
Teva's CGRP-Inhibitor Reduced Monthly Migraine Days in Late-Stage Trial | BioSpace
Identifying New Antimigraine Targets: Lessons from Molecular Biology: Trends in Pharmacological Sciences
Anti-CGRP (Calcitonin Gene-Related Peptide) biologics: a new era for migraine prevention | Neurologybytes
Teva, after locking up new Ajovy patents, sues Eli Lilly again in heated migraine drug fight | FiercePharma
Ajovy, Teva's migraine drug, recommended by UK's NICE.
CGRP monoclonal antibodies reduce headaches in older patients
Calcitonin Gene-Related Peptides | CGRP Antibodies For Migraine - MigrainePal
Teva's AJOVY Approved for Migraine Prevention
Teva's migraine prophylaxis drug now approved in Europe
Teva launches pre-filled pen for anti-CGRP migraine therapy AJOVY®▽ (fremanezumab) in the UK - ACNR | Paper & Online Neurology Journal ACNR | Paper & Online Neurology Journal
Teva's migraine med given marketing authorization
Robust data and flexible approach put Teva in pole position with anti-CGRP drug in UK
Fremanezumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Teva tries to make something out of nothing with Ajovy approval | Evaluate
Teva's migraine injection approved in Europe - PMLiVE
Teva bows out of chronic cluster headache as CGRP drug fizzles in phase 3 | FierceBiotech
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Sverige
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults
CGRP-targeted antibodies in difficult-to-treat migraine | Nature Reviews Neurology
Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans - ScienceDirect
